| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2018 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 7.5k | $10.29 | $77.2k | | 05/31/2018 |
| 05/09/2018 | Krystal Biotech, Inc. | KRYS | Purchase | Common Stock | 9k | $10.42 | $93.8k | | 05/09/2018 |
| 05/10/2017 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 2k | $0.00 | $0 | | 05/10/2017 |
| 09/23/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 7.2k | $128.81 | $927.7k | | 09/23/2016 |
| 09/23/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 2.8k | $130.03 | $364.1k | | 09/23/2016 |
| 09/23/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 3.7k | $131.10 | $488.2k | | 09/23/2016 |
| 09/23/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 1.8k | $131.97 | $234.1k | | 09/23/2016 |
| 05/11/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Option to Purchase Common Stock | 2.3k | $138.86 | $318.5k | | 05/11/2016 |
| 05/11/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 835 | $0.00 | $0 | | 05/11/2016 |
| 09/15/2012 | InvenSense Inc | INVN | Grant | Stock Option (right to buy) | 20k | $13.18 | $263.6k | | 09/15/2012 |
| 10/28/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 26.1k | $68.00 | $1.8M | | 10/27/2011 |
| 10/28/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 15k | $4.93 | $74k | | 10/27/2011 |
| 10/28/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 11.1k | $5.55 | $61.7k | | 10/27/2011 |
| 10/27/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 18.9k | $5.55 | $104.8k | | 10/27/2011 |
| 10/27/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 18.9k | $68.00 | $1.3M | | 10/27/2011 |
| 05/11/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Option to Purchase Common Stock | 2.8k | $98.86 | $275.4k | | 05/11/2011 |
| 02/14/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 23k | $89.93 | $2.1M | | 02/14/2011 |
| 02/14/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 8k | $5.37 | $43k | | 02/14/2011 |
| 02/14/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 15k | $8.53 | $128k | | 02/14/2011 |